help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhasin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhasin, S.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 10 3435-3436
Copyright © 1998 by The Endocrine Society


Special Articles

I. Introduction

Shalender Bhasin

Charles R. Drew University of Medicine and Science and University of California Los Angeles School of Medicine Los Angeles, California 90059


    Introduction
 Top
 Introduction
 References
 
OF THE one thousand generations of humans that have lived on this planet, only the men of the last two generations could have hoped to live past the age of 50! Since 1900, the number of Americans 65 yr of age or older has increased 11-fold, from 3.1 million to 33.9 million (1). By 2030, this number will have doubled again to 70 million. The older population is also getting older: while the 65–74 age group is eight times larger now than it was in 1900, the 85+ group is 31 times larger (1). Because of these powerful demographic trends brought about by increasing life expectancy, frailty, impaired sense of well-being, and sexual dysfunction have emerged as important quality-of-life issues for aging men.

Ancient Indians, Greeks, and Egyptians were aware that extracts of animal testis could promote virility, potency, and vigor in men. In modern times, the castration and testis-transplantation experiments in roosters, conducted initially by John Hunter (2) and later by Adolf Berthold (3), established the link between secretions of the testis and some of the sexually dimorphic features in the rooster. Brown- Sequard (4) recognized the association between changes in testicular function and the loss of vigor in older men; he claimed to have rejuvenated himself by injecting the extracts of guinea pig testis. In the 1930s, Butenandt (5) and Ruzicka shared the Nobel Prize for the chemical synthesis of testosterone. Although testosterone was the first hormone to be discovered and one of the first hormones to be chemically synthesized, it is ironic that we are just beginning to learn about its role in the aging process in men.

There is agreement that testosterone levels decrease with advancing age in men; however, the significance of this decrease remains unclear. We do not know whether testosterone replacement therapy in older men would have beneficial effects on muscle function, sexual function, sense of well being, and quality of life, or whether this could be done safely. There is uncertainty about the long-term effects of testosterone administration on the prostate and on the cardiovascular system. Recognizing the relative paucity of definitive data, the increasing public interest, and the controversial nature of this issue, The Journal of Clinical Endocrinology & Metabolism invited several experts to present their opinions on unresolved questions related to androgen replacement in older men. Are older men hypogonadal? How should we define hypogonadism in older men? What testosterone assay has the best discriminating ability in older men? When should free testosterone levels be measured and by what method? Can testosterone supplementation produce clinically meaningful changes in body composition and muscle function in older men? Should testosterone be given to older men with sexual dysfunction and low normal testosterone levels? What are the long-term risks of testosterone replacement in older men? How should a clinician manage an older man presenting with low testosterone levels, or with sexual dysfunction and other symptoms of hypogonadism? How should testosterone replacement be administered and monitored in older men? What are the methodological and research design problems in the conduct and interpretation of studies of testosterone replacement in older men?

It is well to remember that the debate over the relative risks and benefits of estrogen therapy in women has raged for 30 yr, and clarity has only recently begun to emerge in that field. In contrast, the debate over testosterone replacement in older men has just started; the ponderous issues of risks and benefits are unlikely to be resolved anytime soon.


    Footnotes
 
Address all correspondence regarding these controversies and requests for reprints to: Shalender Bhasin, Chief, Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Science, and Professor of Medicine, University of California Los Angeles School of Medicine, Los Angeles, California 90059. Reprints of the Therapeutic Controversies will include all authors and all pages, as they appear in the journal.

Accepted May 19, 1998.


    References
 Top
 Introduction
 References
 

  1. Fowles DG. 1997 A profile of older Americans: 1997. U.S. Department of Health and Human Services; Washington, DC: American Association of Retired Persons and the Administration on Aging.
  2. Irvine W. 1928 John Hunter’s experiments: evidence of an eyewitness. Letter to Professor Thomas Hamilton, University of Glasgow, June 17, 1771. Lancet. 359–360.
  3. Berthold AA. 1849 Transplantation der Hoden. Arch Anat Physiol Wiss Med. 42–46.
  4. Brown-Sequard CE. 1889 Des effects produits chez Phomme par des injections souscutanées d’un liquide retire des testicules frais de cobaye et de chien. CR Seanc Soc Biol. 1:420–430.
  5. Butenandt A. 1931 Uber die chemische Unterschung der sexual hormones. Z. Angew Chem. 44:905–908.



This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
L. Katznelson, M. W Robinson, C. L Coyle, H. Lee, and C. E Farrell
Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men
Eur. J. Endocrinol., December 1, 2006; 155(6): 867 - 875.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. A. Bauman, A. M. Spungen, J. Wang, R. N. Pierson Jr., and E. Schwartz
Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1098 - E1103.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. Wald, R. B. Meacham, L. S. Ross, and C. S. Niederberger
Testosterone Replacement Therapy for Older Men
J Androl, March 1, 2006; 27(2): 126 - 132.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Laghi, A. Antonescu-Turcu, E. Collins, J. Segal, D. E. Tobin, A. Jubran, and M. J. Tobin
Hypogonadism in Men with Chronic Obstructive Pulmonary Disease: Prevalence and Quality of Life
Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 728 - 733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Laghi, W. E. Langbein, A. Antonescu-Turcu, A. Jubran, C. Bammert, and M. J. Tobin
Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 598 - 605.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
P. J. Schmidt, K. L. Berlin, M. A. Danaceau, A. Neeren, N. A. Haq, C. A. Roca, and D. R. Rubinow
The Effects of Pharmacologically Induced Hypogonadism on Mood in Healthy Men
Arch Gen Psychiatry, October 1, 2004; 61(10): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Korbonits, M. Slawik, D. Cullen, R. J. Ross, G. Stalla, H. Schneider, M. Reincke, P. M. Bouloux, and A. B. Grossman
A Comparison of a Novel Testosterone Bioadhesive Buccal System, Striant, with a Testosterone Adhesive Patch in Hypogonadal Males
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2039 - 2043.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. S. Tremblay, J. L. Copeland, and W. Van Helder
Effect of training status and exercise mode on endogenous steroid hormones in men
J Appl Physiol, February 1, 2004; 96(2): 531 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee
Endogenous Sex Hormones and Cardiovascular Disease in Men
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. C. Creutzberg, E. F. M. Wouters, R. Mostert, R. J. Pluymers, and A. M. W. J. Schols
A Role for Anabolic Steroids in the Rehabilitation of Patients With COPD?: A Double-Blind, Placebo-Controlled, Randomized Trial
Chest, November 1, 2003; 124(5): 1733 - 1742.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Callies, H. Stromer, R. H. G. Schwinger, B. Bolck, K. Hu, S. Frantz, A. Leupold, S. Beer, B. Allolio, and A. W. Bonz
Administration of Testosterone Is Associated with a Reduced Susceptibility to Myocardial Ischemia
Endocrinology, October 1, 2003; 144(10): 4478 - 4483.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, and R.A. Anderson
Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men
Hum. Reprod., June 1, 2002; 17(6): 1490 - 1501.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. B. Singh, S. Hsia, P. Alaupovic, I. Sinha-Hikim, L. Woodhouse, T. A. Buchanan, R. Shen, R. Bross, N. Berman, and S. Bhasin
The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young Men
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 136 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Vermeulen
Androgen Replacement Therapy in the Aging Male--A Critical Evaluation
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390.
[Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
H. C. Margolese
The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male--Is There a Link?
J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 93 - 101.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Barrett-Connor, J. E. Mueller, D. G. von Mühlen, G. A. Laughlin, D. L. Schneider, and D. J. Sartoris
Low Levels of Estradiol Are Associated with Vertebral Fractures in Older Men, But Not Women: The Rancho Bernardo Study
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 219 - 223.
[Abstract] [Full Text]


This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhasin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhasin, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals